Another Series of Strong Earnings Reports For Brand Name Giants Fueled by Egregious Price Increases This week, Big Pharma giant AbbVie and Amgen both held earnings calls for the third quarter where they reported financials that topped Wall Street analysts’ expectations. The strong earnings follow price hikes earlier in the year from both brand name […]
Broad-based Coalition of Advocates, Including AARP and Patients for Affordable Drugs Now, Encourage Lawmakers to Boost Competition, Hold Big Pharma Accountable to Lower Drug Prices In case you missed it, on Wednesday, The Campaign for Sustainable Rx Pricing (CSRxP) joined more than 50 organizations, including AARP and Patients for Affordable Drugs Now, on a letter […]
New Analysis Finds Drug Companies Continue to Price-Gouge American Patients, Increase Prices on Brand Name Drugs Used to Treat Serious Conditions An analysis released Wednesday by the Center for American Progress (CAP) found that Big Pharma increased prices on 112 medications above the annual inflation rate in July of this year. To conduct the analysis, […]
More Q3 Earnings From Big Pharma Giants Top Wall Street Expectations Following Price Hikes Earlier In Year As more Big Pharma giants announce third quarter earnings for 2023, price hikes continue to lead to Wall Street besting earnings and profits. This week, Novartis, Merck and Bristol Myers Squibb all reported results for the third quarter […]
Research Exposes How Big Pharma’s Self-Serving Kickbacks Increase Costs and Can Negatively Impact Outcomes for Patients A new paper published by BMJ found that oncologists who received kickback payments from Big Pharma companies were more likely to prescribe non-recommended or lower-value treatments to patients. The study examined prescribing practices for Medicare beneficiaries diagnosed with cancer and […]
Big Pharma Giant Kicks Off Q3 Earnings After Hiking Prices More Than 40 Times This Year This week, brand name drug giant Johnson & Johnson kicked off the first round of Big Pharma earnings calls for the third quarter of 2023. The company surpassed Wall Street analysts’ earnings and profit expectations after having hiked prices […]
Big Pharma Giant Increases Paxlovid Price Weeks After Making Price Hike on COVID-19 Vaccine Official In case you missed it, The Wall Street Journal reported Wednesday that Pfizer will impose a massive price hike on the Big Pharma giant’s brand name COVID-19 treatment Paxlovid as payment shifts from the federal government to the commercial market. […]
Eye Doctors Who Accepted Big Pharma Payments Were More Likely to Prescribe More Expensive Brand Name Products, Leading to Higher Patient and Taxpayer Costs According to a new study in JAMA Health Forum, ophthalmologists who did not accept payments from brand name drug manufacturers were less likely to prescribe higher priced treatments for age-related macular […]
Big Pharma’s Anti-Competitive Tactics Are The Root Cause of Out-of-Control Prescription Drug Prices BIG PHARMA’S PATENT ABUSE IS THE ROOT CAUSE OF OUT-OF-CONTROL PRESCRIPTION DRUG PRICES Big Pharma has a long history of price-gouging American patients through tactics designed to game the U.S. patent system and block competition from more affordable alternatives — enabling Big Pharma to maintain […]
I-MAK Analysis Reveals Patent Abuse on Four Blockbuster Medications Generated $158 Billion for Big Pharma On Tuesday, the Initiative for Medicines, Access, and Knowledge (I-MAK) released a new study detailing the massive financial implications of Big Pharma’s egregious patent thickets meant to block competition from more affordable alternatives to blockbuster brand name prescription drugs. The […]